Related Experiment Video
Updated: Jun 4, 2025
05:29
Imaging and Quantifying Mitochondrial Morphology in C. elegans During Aging
Published on: January 17, 2025
786
Aging promotes an increase in mitochondrial fragmentation in astrocytes
Ana Paula Bergamo Araujo1, Gabriele Vargas1, Lívia de Sá Hayashide1
1Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Frontiers in Cellular Neuroscience
|December 20, 2024
Summary
Brain aging causes mitochondrial fragmentation in astrocytes, impacting brain function. This study reveals key molecular changes, suggesting mitochondrial fragmentation as a therapeutic target for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Cell Biology
- Aging Research
Background:
- Brain aging is linked to metabolic changes and cellular senescence.
- Mitochondrial dysfunction and reduced energy production contribute to neurodegeneration.
Purpose of the Study:
- To investigate mitochondrial changes in astrocytes and neurons during brain aging.
- To explore the role of mitochondrial fragmentation in astrocytic dysfunction.
Main Methods:
- Comparative analysis of young and aged mice.
- In vitro studies on senescent astrocytes.
- Mitochondrial content, biogenesis, membrane potential, and fragmentation analysis.
- Protein level quantification (qPCR, immunocytochemistry) and electron microscopy.
Main Results:
- Aged animals showed reduced mitochondrial content and biogenesis in astrocytes and neurons.
- Senescent astrocytes exhibited decreased mitochondrial membrane potential and increased fragmentation.
- Elevated levels of fusion proteins and DRP1 (fission regulator) were observed.
- Mitochondria in aged astrocytes were smaller and more fragmented, with increased DRP1 phosphorylation.
Conclusions:
- Brain aging is associated with significant mitochondrial fragmentation in astrocytes.
- This fragmentation contributes to astrocytic metabolic dysfunction and neurodegeneration.
- Targeting mitochondrial fragmentation may offer therapeutic benefits for age-related brain diseases.
